WZ4002

CAS No. 1213269-23-8

WZ4002 ( WZ4002; WZ-4002; WZ 4002 )

Catalog No. M10796 CAS No. 1213269-23-8

WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
10MG 60 In Stock
25MG 107 In Stock
50MG 177 In Stock
100MG 312 In Stock
200MG 464 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WZ4002
  • Note
    Research use only, not for human use.
  • Brief Description
    WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM.
  • Description
    WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM; does not inhibit ERBB2 phosphorylation (T798I).
  • Synonyms
    WZ4002; WZ-4002; WZ 4002
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR (L858R); EGFR (L858R/T790M)
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1213269-23-8
  • Formula Weight
    494.18
  • Molecular Formula
    C25H27ClN6O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO:13 mg/mL (26.3 mM);Ethanol:<1 mg/mL (<1 mM);Water:<1 mg/mL (<1 mM)
  • SMILES
    C=CC(NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C)CC4)C=C3OC)=NC=C2Cl)=C1)=O
  • Chemical Name
    N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)acrylamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhou W, et al. Nature. 2009, 462(7276), 1070-1074.
molnova catalog
related products
  • Afatinib dimaleate

    An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.

  • Cetuximab (anti-EGFR...

    Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).

  • Naquotinib

    Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.